What effect has pneumococcal vaccination had on acute mastoiditis?

Journal of Laryngology and Otology

Volumn 127, Issue SUPPL. 1, 2013, Pages

  Daniel, M ^a,b   Gautam, S ^a   Scrivener, T A ^c   Meller, C ^a   Levin, B ^a   Curotta, J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b Nottingham Hearing Biomedical Research Unit ^*  (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bacteria; Child; Mastoiditis; Otolaryngology; Pneumococcus; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC THERAPY; BACTERIUM ISOLATION; BRAIN DISEASE; CHILD; CHILDHOOD DISEASE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASTOIDITIS; PNEUMOCOCCAL MASTOIDITIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ACUTE DISEASE; ADMINISTRATION, INTRAVENOUS; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; FEMALE; FEVER; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; LEUKOCYTE COUNT; MALE; MASTOIDITIS; NEW SOUTH WALES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84871597691     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112002654     Document Type: Review

References (26)

1. Osborne AJ, Blaser S, Papsin BC. Decisions regarding intracra-nial complications from acute mastoiditis in children. Curr Opin Otolaryngol Head Neck Surg 2011;19:478-85
2. Kværner KJ, Bentdal Y, Karevold G. Acute mastoiditis in Norway: no evidence for an increase. Int J Pediatr Otorhinolaryngol 2007;71:1579-83
3. Austin B, Work WP. Intracranial complications of otitic origin. Laryngoscope 1966;76:288-308
4. Schwartz MW, ed. The 5-minute Pediatric Consult, 5th edn. Philadelphia, USA: Lippincott Williams & Wilkins, 2008
5. Van Den Aardweg M, Rovers MM, Alexander de Ru J, Albers FWJ, Schilder AGM. A systematic review of diagnostic criteria for acute mastoiditis in children. Otol Neurotol 2008;29:751-7
6. O'Connor TE, Perry CF, Lannigan FJ. Complications of otitis media in Indigenous and non-indigenous children. Med J Aust 2009;191:60-4
7. Bahadori RS, Schwartz RH, Ziai M. Acute mastoiditis in children: an increase in frequency in Northern Virginia. Pediatr Infect Dis J 2000;19:212-15
8. Spratley J, Silveira H, Alvarez I, Pais-Clemente M. Acute mas-toiditis in children: review of the current status. Int J Pediatr Otorhinolaryngol 2000;56:33-40
9. Katz A, Leibovitz E, Greenberg D, Raiz S, Greenwald-Maimon M, Leiberman A et al. Acute mastoiditis in Southern Israel: a twelve-year retrospective study (1990 through 2001). Pediatr Infect Dis 2003;22:878-82
10. Nussinovitch M, Yoeli R, Elishkevitz K, Varsano I. Acute mas-toiditis in children: epidemiologic, clinical, microbiologic, and therapeutic aspects over past years. Clin Pediatr 2004;43:261-7
11. Antonelli PJ, Dhanani N, Giannoni CM, Kubilis PS. Impact of resistant pneumococcus on rates of acute mastoiditis. Otolaryngol Head Neck Surg 1999;121:190-4
12. Roddy MG, Glazier SS, Agrawal D. Pediatric mastoiditis in the pneumococcal conjugate vaccine era. Pediatr Emerg Care 2007; 23:779-84
13. Quesnel S, Nguyen M, Pierrot S, Contencin P, Manach Y, Couloigner V. Acute mastoiditis in children: a retrospective study of 188 patients. Int J Pediatr Otorhinolaryngol 2010;74: 1388-92
14. Zangeneh TT, Baracco G, Al-Tawfiq JA. Impact of conjugate pneumoccal vaccines on the changing epidemiology of pneumo-coccal infections. Expert Rev Vaccines 2011;10:345-53
15. Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Continued control of pneumococcal disease in the UK-the impact of vaccination. J Med Microbiol 2011;60:1-8
16. Stamboulidis K, Chatzaki D, Poulakou G, Loannidou S, Lebessi E, Katsarolis I et al. The impact of the heptavalent pneumococ-cal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 2011;30:551-5
17. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R et al. Community-wide vaccination with the heptavalent pneu-mococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004;23:829-33
18. Eskola J, Kilpi T, Palmu A, Jokinen J, Eerola M, Haapakoski J et al. Finnish Otitis Media Study Group. Efficacy of a pneumo-coccal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9
19. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011;378: 1962-73
20. Ansaldi F, Florentis D, Canepa P, Bandettini R, Diana MC, Martini M et al. Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines. Hum Vaccin 2011;7(suppl):211-16
21. Ongkasuwan J, Valdez TA, Hulten KG, Mason EO, Kaplan SL. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19a isolates. Pediatrics 2008;122: 34-9
22. Jacobs MR, Good CE, Bajaksouzian S, Windau A. Emergence of streptococcus pneumoniae serotypes 19A, 6C and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008;47:1388-95
23. Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010;16:217-25
24. Choi SS, Lander L. Pediatric acute mastoiditis in the post-pneu-mococcal conjugate vaccine era. Laryngoscope 2011;121: 1072-80
25. Singleton RJ, Hennessey TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-92
26. Pang LH, Barakate MS, Havas TE. Mastoiditis in a paediatric population: a review of 11 years experience in management. Int J Pediatr Otorhinolaryngol 2009;73:1520-4